AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
Condition: Advanced Non-small-cell Lung Cancer Interventions: Drug: AK112; Drug: AK104; Drug: caboplatin; Drug: paclitaxel; Drug: pemetrexed; Drug: Docetaxel Sponsor: Akeso Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials